Senju Pharmaceutical Co. v. Lupin Ltd.
District Court, D. New Jersey
1Opinion of the Court
MARKMAN OPINION
SIMANDLE, Chief Judge:
I. INTRODUCTION
Plaintiffs Senju Pharmaceútical Co., Ltd., Bausch & Lomb Inc., and Bausch & Lomb Pharma Holdings Corp. (collectively, “Plaintiffs”) brought these various patent infringement actions under the Hatch-Waxman Act, 35 U.S.C. §§ 271, 281, against Defendants Lupin, Ltd., Lupin Pharmaceuticals, Inc., Innopharma Licensing, Inc., Innopharma Licensing, LLC, In-nopharma, Inc., and Innopharma, LLC (collectively, “Defendants”) concerning Defendants’ submissions of abbreviated new drug applications (“ANDAs”) seeking FDA approval to market a generic version…
2Cases cited23 opinions
- MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al.Supreme Court of the United States · 1996
- Edward H. Phillips v. Awh Corporation, Hopeman Brothers, Inc., and Lofton Corporation, Defendants-CrossCourt of Appeals for the Federal Circuit · 2006
- Vitronics Corporation v. Conceptronic, Inc.Court of Appeals for the Federal Circuit · 1996
- Nautilus, Inc. v. Biosig Instruments, Inc.Supreme Court of the United States · 2014
- Ccs Fitness, Inc. v. Brunswick Corporation and Its Division Life FitnessCourt of Appeals for the Federal Circuit · 2002
18 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- Ingenus Pharmaceuticals, LLC v. Nexus Pharmaceuticals, Inc.District Court, N.D. Illinois · 2025
- VIFOR (INTERNATIONAL) AG v. MYLAN LABORATORIES LTD.District Court, D. New Jersey · 2021